Evidence map›Paper›PMID 37823665›Full record

ArticleJournal of clinical microbiology2023

Direct prediction of carbapenem resistance in

Bing Liu, Jianpeng Gao, Xue Fei Liu, Guanhua Rao, Jiajie Luo, Peng Han, Weiting Hu, Ze Zhang, Qianqian Zhao, Lizhong Han and 2 more

Open access · greenAbstract read
In one paragraph

Article in Journal of clinical microbiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 1 pooled it
2.8field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 1 synthesis or guideline pooled it, 29 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. Article
  5. Article
  6. Article
  7. Early risk stratification for carbapenem resistance amongFrontiers in cellular and infection microbiology · 2026
    Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Bing Liu *Department of Pulmonary and Critical Care Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine , Shanghai, China.ORCID 0000-0001-9314-2072
Jianpeng Gao *Genskey Medical Technology Co., Ltd. , Beijing, China.
Xue Fei LiuDepartment of Pulmonary and Critical Care Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine , Shanghai, China.
Guanhua RaoGenskey Medical Technology Co., Ltd. , Beijing, China.ORCID 0000-0003-4408-208X
Jiajie LuoGenskey Medical Technology Co., Ltd. , Beijing, China.
Peng HanGenskey Medical Technology Co., Ltd. , Beijing, China.
Weiting HuDepartment of Pulmonary and Critical Care Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine , Shanghai, China.
Ze ZhangDepartment of Pulmonary and Critical Care Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine , Shanghai, China.
Qianqian ZhaoDepartment of Pulmonary and Critical Care Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine , Shanghai, China.
Lizhong HanDepartment of Clinical Microbiology,, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine , Shanghai, China.ORCID 0000-0001-5737-9785
Zhi JiangGenskey Medical Technology Co., Ltd. , Beijing, China.ORCID 0009-0007-5580-2448
Min ZhouDepartment of Pulmonary and Critical Care Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine , Shanghai, China.ORCID 0000-0002-8718-8506
Shanghai Jiao Tong University · CN

Funding

Cultivation Projection of Shanghai Major Infectious Disease Research Base 20dz2210500MOST | National Key Research and Development Program of China (NKPs) 2017YFC1309700, 2017YFC1309701Shanghai Key Laboratory of Emergency Prevention, Diagnosis and Treatment of Respiratory Infectious Diseases 20dz2261100Shanghai Municipal Key Clinical Specialty shslczdzk02202Shanghai Top-Priority Clinical Key Disciplines Construction Project 2017ZZ02014
6 · The paper itself

Abstract

Carbapenem resistance is a major concern in the management of antibiotic-resistant

Indexed as

Pseudomonas aeruginosaPseudomonas InfectionsAnti-Bacterial AgentsBacterial Proteinsbeta-LactamasesCarbapenemsDrug Resistance, BacterialHumansMeropenemMicrobial Sensitivity TestsPorinsWhole Genome SequencingAnti-Bacterial AgentsBacterial Proteinsbeta-LactamasesCarbapenemsMeropenemPorinscarbapenem resistance predictionmachine learningmetagenomic sequencingPseudomonas aeruginosawhole genome sequencing

Identifiers

PMID37823665
PMCPMC10662344
OpenAlexW4387562881

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.